Is your biotech ready for the EU market?
Scientific accuracy · Regulatory positioning · Communication clarity · AI discoverability
Many biotech companies struggle with how their communication lands across European audiences and AI-driven discovery. In a few minutes, see where your communication stands across science, regulatory positioning, clarity, and AI discoverability — for the EU market and beyond.
How it works
Country, product type, and the EU audience you want to reach.
Paste your website text and optionally upload up to 2 PDFs.
Instant audit, downloadable PDF, and an Auralis review offer.
What we evaluate
Four dimensions that decide whether your content lands or loses credibility with European decision-makers.
Specific, verifiable claims. Correct terminology. Evidence where claims are made.
How clearly you communicate regulatory stage (CE/IVDR/MDR/FDA/RUO) — not a compliance verdict.
Professional English, logical structure, value proposition that fits EU buyers.
Structured to be cited by ChatGPT, Claude, Perplexity. Direct answers, clean entities.
About Auralis Biotech
Auralis Biotech is the commercial partner for innovators across biotech, pharma, drug discovery, biopharma, life sciences, animal health, food safety, AI-driven platforms and beyond — from non-EU companies entering Europe, to EU companies in BUILD, GROWTH, and SCALE stages. We help you build credible, compliant, and effective communication, from scientific accuracy to regulatory positioning to AI-era discoverability.
